Abbott Laboratories is considering pulling infant formula for premature babies off the market, Chief Executive Officer Robert Ford said, amid investor concerns about lawsuits over its safety. The fortified formula, designed for fragile infants under medical supervision, has drawn fire …
Source: Claims Journal